Cytoplasmic ATP and Ca 2+ are implicated in current models of glucose's control of glucagon and insulin secretion from pancreatic a-and b-cells, respectively, but little is known about ATP and its relation to Ca 2+ in a-cells. . The data indicate that an a-cell-intrinsic mechanism controls glucagon in hypoglycemia and that paracrine factors shape pulsatile secretion in hyperglycemia.-Li, J., Yu, Q., Ahooghalandari, P., Gribble, F. M., Reimann, F., Tengholm, A., Gylfe, E. Submembrane ATP and Ca 2+ kinetics in a-cells: unexpected signaling for glucagon secretion. FASEB J. 29, 3379-3388 (2015). www.fasebj.org Key Words: oscillations • islet of Langerhans • signal transduction • paracrine INSULIN AND GLUCAGON HAVE CENTRAL roles in maintaining normal glycemia by lowering and increasing blood glucose, respectively. The circulating concentrations of both hormones oscillate (1, 2), which promotes hormone action by keeping the receptors up-regulated (3). Consistent with their opposing effects, the oscillations of circulating insulin and glucagon are synchronized in opposite phase (1, 2), as is the underlying pulsatile release of insulin and glucagon from isolated human (4) or mouse (5) pancreatic islets. In type 2 diabetes, the regular insulin oscillations deteriorate (6, 7), and prediabetes is associated with loss of the characteristic phase relationship between the insulin and glucagon oscillations (2). These changes may contribute to b-cell exhaustion and diabetes, because more insulin is needed after down-regulation of its receptors, and glucose storage/production by the liver is perturbed when insulin and glucagon no longer vary in opposite phase.
INSULIN AND GLUCAGON HAVE CENTRAL roles in maintaining normal glycemia by lowering and increasing blood glucose, respectively. The circulating concentrations of both hormones oscillate (1, 2) , which promotes hormone action by keeping the receptors up-regulated (3) . Consistent with their opposing effects, the oscillations of circulating insulin and glucagon are synchronized in opposite phase (1, 2) , as is the underlying pulsatile release of insulin and glucagon from isolated human (4) or mouse (5) pancreatic islets. In type 2 diabetes, the regular insulin oscillations deteriorate (6, 7) , and prediabetes is associated with loss of the characteristic phase relationship between the insulin and glucagon oscillations (2) . These changes may contribute to b-cell exhaustion and diabetes, because more insulin is needed after down-regulation of its receptors, and glucose storage/production by the liver is perturbed when insulin and glucagon no longer vary in opposite phase.
There is consensus about the central mechanisms underlying glucose regulation of insulin secretion from b-cells, with rapid uptake and metabolism of the sugar, generation of ATP, and closure of ATP-sensitive K + (K ATP ) channels resulting in depolarization with influx of secretion-triggering Ca 2+ through voltage-dependent channels (8) . In contrast, the processes by which glucagon release from a-cells is stimulated in response to hypoglycemia and is inhibited when normal glycemia is reestablished continue to puzzle the scientific community. Glucose may act indirectly via autonomic (9, 10) and paracrine (11) (12) (13) (14) (15) mechanisms, but there is also strong evidence of direct glucose sensing by the a-cells (16) (17) (18) (19) (20) . ATP is also a key player in different models of glucoseregulated glucagon secretion from the a-cell, but its role varies considerably. Glucose-generated ATP has thus been thought to mediate reduction of voltage-dependent Ca 2+ influx and exocytosis in a-cells (21) by a-cell hyperpolarization induced by providing energy to the electrogenic Na + /K + pump (16) or by shutting off a depolarizing storeoperated current after energizing sarco(endo)plasmic Ca 2+ -ATPase (18, 20) . It has also been suggested that glucoseinduced elevation of the ATP/ADP ratio, as in b-cells, closes ; FBS, fetal bovine serum; GLU-RFP mice, transgenic mice expressing red fluorescent protein under proglucagon promoter control; K ATP channels, ATP-sensitive K + channels; RFP, red fluorescent protein; SSTR, somatostatin receptor; TIRF, total internal reflection fluorescence K ATP channels to depolarize the a-cells, which paradoxically inhibits voltage-dependent Ca 2+ influx and glucagon release (17, 19) . A fourth alternative is that the glucose-induced elevation of ATP is associated with a reduction of AMP-activated protein kinase activity, which inhibits glucagon release by a mechanism that may be partly Ca 2+ independent (22) . Although all these models involve glucose-induced generation of ATP, relatively little is know about ATP kinetics in the a-cell. Measurements on purified rat islet cell populations confirmed that an increase in glucose concentration raises ATP and the ATP/ADP ratio in b-cells, but there are no changes in the nucleotides in the a-cells, which already have a relatively high ATP/ADP ratio at low glucose concentrations (23) . In later studies of mouse islets with luciferase-expressing a-cells, there were modest elevations of ATP in response to 15-20 mM glucose (11, 14) concentrations, much higher than the 7-8 mM that maximally inhibits secretion (20, 24) . Recently, changes in glucose concentration of between 1 and 6 mM were found to induce reversible responses of the ATP-binding fluorescent probe Perceval in red fluorescent protein (RFP)-expressing a-cells of transgenic GLU-RFP mice (mice expressing RFP under proglucagon promoter control) (25) .
In the present study, we used Perceval (26) 
MATERIALS AND METHODS

Materials and experimental medium
The primary polyclonal rabbit anti-insulin antibody was from Abcam (Cambridge, United Kingdom), and the primary polyclonal rabbit anti-glucagon antibody was from Dako (Carpinteria, CA, USA). The secondary antibody Alexa Flour 488 goat anti-rabbit IgG was from Life Technologies (Rockville, MD, USA). Poly-L-lysine, diazoxide, glutamic acid, and HEPES were from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS) was from Life Technologies-Gibco (Grand Island, NY, USA). The insulin and SSTR-2 antagonists S961 and PRL2903 were kind gifts from Novo Nordisk, Bagsvaerd, Denmark, and Dr. D. H. Coy (Tulane University, New Orleans, LA, USA), respectively. Adenovirus encoding the fluorescent ATP biosensor construct Perceval (26) was used according to a published method (29) . Superfusion and batch incubation of islets were made with experimental medium containing 138 mM NaCl, 4.8 mM KCl, 1.2 mM MgCl 2 , 1.3 or 2.6 (hormone release) mM CaCl 2 , 3 mM glucose, 0.5 mg/ml BSA, and 25 mM HEPES with pH adjusted to 7.4 with NaOH.
Animals, islet isolation, cell culture, and virus infection
All animal experimental procedures were approved by the local ethics committee for use of laboratory animals in Uppsala, Sweden. Transgenic mice with homozygous expression of RFP in a-cells activated by proglucagon promoter-driven Cre-mediated excision of a stop codon (GLU-RFP mice) were produced in Cambridge (30), followed by backcrossing for 8 generations into the C57Bl/6J strain and continued breeding in Uppsala. Normal C57Bl/6J mice were obtained from Taconic (Ry, Denmark). Islets of Langerhans were isolated by collagenase digestion of the pancreas (20) from 4-to 12-mo-old mice. After isolation, the islets were cultured for 18-24 h in RPMI 1640 medium containing 5.5 mM glucose, 10% FBS, 100 units/ml penicillin, and 100 mg/ml streptomycin, at 37°C in an atmosphere of 5% CO 2 in humidified air.
For ATP measurements, the islets were infected with the Perceval adenovirus at concentrations of 1-2 3 10 6 plaque-forming units/islet or 20 plaque-forming units/cell for 1-2 h. During infection, the concentration of serum was reduced to 2%. The islets were subsequently washed 3 times with normal RPMI 1640 medium and cultured for at least 18 h before use. 
Immunostaining
Immunostaining was performed at room temperature, unless otherwise stated, with PBS. Isolated islets were thoroughly rinsed and then fixed with 4% paraformaldehyde for 10 min, followed by cell permeabilization by exposure to 0.2% Triton X-100 on ice for 10 min. Nonspecific antigens were blocked by 30 min exposure to 5% FBS (blocking buffer). The islets were then incubated for 2 h with rabbit polyclonal anti-insulin or -glucagon diluted 1:100 in blocking buffer followed by 3 washes. Subsequently, the islets were incubated in darkness for 1 h with Alexa Fluor 488 goat anti-rabbit IgG diluted 1:200 in blocking buffer. The islets were then washed 4 times for 5 min in 0.1% Tween-20 to reduce background, followed by 3 additional washings in PBS.
Confocal microscopy
A previously described confocal microscope setup (29) was used to image immunostained islets with excitation/emission at 488/527 nm for Alexa Fluor 488 and 561 and/or .645 nm for RFP.
Measurements of hormone release
Batches of 8-10 size-matched islets were preincubated at 37°C for 30 min in experimental medium containing 3 mM glucose followed by incubation for 40 min in 500 ml medium containing 3 or 20 mM glucose and hormone receptor antagonists, as indicated in Fig. 6 . The incubation medium was then collected, and the islets were briefly sonicated in acid ethanol. Samples from the medium and islets were appropriately diluted and taken for duplicate assays of glucagon and insulin. Glucagon was measured with an ELISA kit from Mercodia AB (Uppsala, Sweden), according to instructions, and insulin was determined with a mouse/rat insulin immunoassay kit from Mesoscale Discovery (Rockville, MD, USA) with custom-optimized protocol. Secretion was then expressed as a percentage of total hormone content. 
Data and statistical analysis
RESULTS
Identification of a-and b-cells
To facilitate cell identification, islets were isolated from GLU-RFP mice with RFP-expressing a-cells. Confocal imaging of immunostained islets showed that nearly all of the RFP-positive and -negative cells were a-and b-cells, respectively (Supplemental Fig. S1 ). However, unexpected problems became apparent after infection with the ATP sensor Perceval, which interacted with RFP to produce erratic responses affecting both fluorophores in the a-cells (Supplemental Fig. S2 ). Because the RFP did ] pm levels in 3 mM glucose, and introduction of 20 mM glucose caused a b-cell-characteristic (34) initial decrease in Ca 2+ , followed by prompt and prolonged elevation and pronounced, regular, slow oscillations that were almost perfectly synchronized between the different b-cells (Fig. 1) ] pm patterns in 3 and 20 mM glucose, and glutamate responsiveness were therefore always used to discriminate between a-and b-cells.
The ATP response to glucose is left shifted and less pronounced in a-than in b-cells Subsequent studies of [ATP] pm kinetics were made with Perceval-infected islets from regular C57Bl/6J mice.
To
2+ affinity, and more rapid photobleaching, it served rather well together with Perceval, and there was no interference between the probes (see below). Considering the implication of ATP in glucose-regulated glucagon and insulin release, we next compared [ATP] pm in the 2 cell types at glucose concentrations covering the glucose control range for both hormones (Fig. 2) . Increase in glucose from 1 to 5 mM, which induces pronounced inhibition of glucagon release but fails to stimulate insulin secretion from mouse islets (20, 24) , caused a similarly rapid elevation of Perceval fluorescence in a-and b-cells (Fig. 2) . Whereas the modest a-cell response was close to maximal after 2-3 min, Perceval fluorescence continued to increase for 5 min in the b-cells and then declined to a level corresponding to 9% above the initial baseline, as compared to 5% in the a-cells (P , 0.001). Further glucose elevation to 20 mM to stimulate insulin release caused a more pronounced increase in Perceval fluorescence in b-than in a-cells (49% vs. 12% above baseline; P , 0.001; Fig. 2) . However, the relative increase in Perceval fluorescence in 5 mM glucose was greater in a-than in b-cells (45% vs. 19% of the 20 mM glucose response in each cell type, respectively; Fig. 2, inset) . These data indicate that ATP increased considerably more in b-than in a-cells and that the a-cells showed left-shifted glucose concentration dependence. Subsequent hyperpolarization with diazoxide, which lowered [Ca 2+ ] pm in both a-and b-cells, caused an increase in Perceval fluorescence in both cell types, and under those conditions, glutamate induced a rapid decrease in Perceval fluorescence only in the a-cells (Fig. 2) , likely reflecting the concomitant [Ca 2+ ] pm elevation. A much slower and gradual, but statistically significant, reduction of Perceval fluorescence in the b-cells can be attributed to the time-dependent The islets were initially exposed to 1 mM glucose, and the concentration was then increased to 5 and 20 mM, as indicated. At the end of the experiment, 250 mM diazoxide was added followed by 1 mM glutamate (Glu). Because of timing differences between experiments, the traces are broken and aligned to the time points for media changes (dotted lines). Oscillations were essentially cancelled out when data were averaged from several experiments with differences in timing. The effects of increasing the glucose concentration and adding diazoxide and glutamate were evaluated by comparing average data during the periods indicated (red bars). Perceval fluorescence (F) is normalized as the F/F 0 ratio, where F 0 is the initial fluorescence. Inset: steady-state [ATP] pm at 5 mM glucose in a-(blue) and b-(gray) cells after normalization to the levels at 1 and 20 mM glucose (0 and 100%, respectively). Fig. S2) (Fig. 3) .
When we compared the [ATP] pm kinetics in the 4 a-and 11 b-cells within the same islet, it became evident that oscillations induced by 20 mM glucose are synchronized between the 2 cell types, with the highest positive correlation when the traces were not time shifted (Fig. 4) . ] pm oscillations in a-and b-cells were observed in another 7 islets from 6 different mice.
Insulin secretion from human (4) and mouse (5) pancreatic islets exposed to 20 mM glucose is pulsatile, and studies of mouse islets and insulinoma cells have demonstrated that secretory pulses are driven by synchronous oscillations of the cytoplasmic concentrations of Ca 2+ and cAMP (28, 31) . In addition, glucagon secretion is pulsatile at 20 mM glucose, and the pulses are in opposite phase to those of insulin (4, 5) . Because Ca 2+ is supposed to be an equally important trigger of glucagon release, the synchronized [Ca 2+ ] pm oscillations between a-and b-cells is utterly surprising. To challenge this unexpected finding, we performed additional [Ca 2+ ] pm recordings with the superior Fluo-4 indicator in the transgenic GLU-RFP mice. Figure 5 shows data from 13 a-and 6 b-cells in the same islet, providing additional evidence that glucose induces synchronized [Ca 2+ ] pm oscillations in the 2 cell types. Similar synchronization was observed in another 36 experiments with Fluo-4-loaded islets from 21 different GLU-RFP mice.
An SSTR-2 antagonist potently stimulates glucagon and insulin secretion but has only modest effects on [Ca 2+ ] pm signaling in a-and b-cells
In view of the unexpected synchronization between [Ca
2+
] pm oscillations in a-and b-cells exposed to 20 mM glucose, we explored the possibility that glucagon secretion under these conditions is determined by paracrine factors independent of [Ca 2+ ] pm . Both somatostatin and insulin have been implicated in glucose regulation of glucagon release (36, 37) , and we therefore compared how receptor antagonists to these hormones affected glucagon and insulin release from islets in relation to their effects on [Ca 2+ ] pm . An increase in glucose from 3 to 20 mM stimulated insulin release 25-fold and inhibited glucagon secretion by 65% (Fig. 6) . The insulin receptor antagonist S961 did not significantly affect glucagon or insulin release at either glucose concentration, whereas the SSTR-2 antagonist PRL2903 potently stimulated glucagon release at both 3 (12-fold) and 20 (21-fold) mM glucose. However, in accordance with a previous observation (20) , the presence of PRL2903 did not seem to prevent a 40% inhibition of glucagon release by 20 mM glucose, although this effect did not reach statistical significance in the present study. Whereas basal insulin secretion at 3 mM glucose was unaffected by PRL2903, secretion stimulated by 20 mM of the sugar was amplified 4-fold. The latter effect is probably indirectly mediated by the pronounced increase in glucagon release, in that SSTR-2 dominates rodent a-cells, whereas the b-cells essentially express type 5 receptors (38) .
S961 had no effect on [Ca 2+ ] pm oscillations in 5 a-and 7 b-cells exposed to 20 mM glucose (Fig. 7A) , whereas PRL2903 transformed glucose-induced slow oscillations of average [Ca 2+ ] pm in 14 b-cells into faster oscillations from an elevated plateau (Fig. 7B) , which is characteristic of a response mediated by glucagon (39) . The PRL2903 effect on average [Ca 2+ ] pm in 4 a-cells was much more subtle, as shown by recordings from the same islet (Fig. 7B) . If anything, a tendency toward a slow oscillatory pattern in Supplemental Figs. S3, S4) . The islet was initially exposed to 3 mM glucose, and the concentration was then increased to 20 mM, as indicated. At the end of the experiment 1, mM glutamate (Glu) was added. The vertical yellow background areas are aligned to coinciding increases in [ATP] pm in the a-and b-cells. The 2-dimensional cross-correlogram (major colored area) was constructed as described in Fig. 3 . 
DISCUSSION
The relatively low proportion of a-cells within pancreatic islets hampers study of the signaling mechanisms that mediate glucose inhibition of glucagon secretion. Attempts to circumvent this difficulty by purifying a-cells from rat (40) and mouse (15) islets with fluorescenceactivated cell sorting led to the unexpected discovery that glucose stimulates glucagon secretion in this preparation. However, it is possible to study individual islet cells in their native location within pancreatic islets using confocal or TIRF imaging techniques. The latter approach has the advantage of accessing only the most superficial layer of islet cells, which is a-cell-rich in rodent islets (41) . Cell identification by immunostaining is usually not feasible, because islet morphology is sufficiently perturbed to prevent confident association of specific responses to cell type. That a-cells show oscillatory Ca 2+ activity at low glucose concentrations when Ca 2+ in the b-cells is low and stable and that Ca 2+ signaling in the b-cells is activated by glucose elevation have been used with confocal microscopy for cell identification within pancreatic islets (42) . These criteria, together with the a-cell-characteristic glutamate response (35) and differences in cell size reflected by the footprint areas, were now used to discriminate between the 2 cell types. The use of transgenic GLU-RFP mice considerably simplified preliminary identification of the a cells, although immunostaining showed that it is not perfect. Therefore, we always complemented RFP-based a-and b-cell identification with functional cytoplasmic Ca 2+ concentration ([Ca 2+ ] i ) characteristics. Indeed, because of the strong interference between Perceval and RFP, we relied entirely on the functional [Ca 2+ ] i responses for the ATP measurements. We were surprised that no Perceval-RFP interference was reported when seemingly identical GLU-RFP mice were used to record the a-cell ATP response to a 1-6 mM glucose increase with confocal microscopy (25) . We found similar interference in control experiments with confocal microscopy. It cannot be attributed to fluorescence bleed-through or altered cell morphology and may involve changes in Ca 2+ or ATP or both, in that K + depolarization also induced parallel changes in RFP and Perceval fluorescence.
Although in prior studies, we calibrated the Perceval fluorescence signal in permeabilized b-cells exposed to different ATP concentrations (29, 43) , it is difficult to perform such calibration in intact islets. Therefore, the present approach does not allow direct comparison of the ATP concentrations in a-and b-cells. In agreement with previous static ATP measurements on purified rat islet cell populations (23) and kinetic recordings on mouse islets with luciferase-expressing a-cells (11, 14) , glucose elevation induced lesser ATP increases in a-than in b-cells, which is consistent with a lower rate of glucose oxidation in a-cells (23, 44) and lesser oxidative phosphorylation efficiency caused by high expression of uncoupling protein 2 (45) . Static measurements of adenine nucleotides in a-cellenriched rat islet fractions have indicated that the total ATP concentration is ;2.2-fold higher than in b-cells at 1 mM glucose (23) . Therefore, it is possible that [ATP] pm is more elevated in a-than in b-cells exposed to low glucose Figure 6 . The SSTR-2 antagonist PRL2903 potently amplifies glucagon and insulin secretion. Glucagon and insulin secretion were measured after a 40 min incubation of mouse pancreatic islets in the presence of 3 or 20 mM glucose and a 20 nM concentration of the insulin receptor antagonist S961 or a 5 mM concentration of the SSTR-2 antagonist PRL2903. Secretion is expressed as a percentage of the total islet hormone content. Bar: means 6 SEM of results in 7 experiments. There were statistically significant differences between the experimental groups (ANOVA; P , 0.001). The post hoc significance levels for the effect of glucose elevation are indicated above the bars and those for the effect of PRL2903 within the bars.
concentrations. When expressed as a percentage of the subsequent response to 20 mM, glucose elevation from 1 to 5 mM induced a much stronger [ATP] pm response in athan in b-cells. The higher a-cell sensitivity at low glucose concentrations is consistent with ATP's involvement in glucose control of glucagon secretion during recovery from hypoglycemia.
Glucose-stimulated insulin release is pulsatile (4, 5) , and the pulses reflect coinciding elevations of the concentrations of triggering Ca 2+ and amplifying cAMP, which show synchronized oscillations in b-cells (31, 46) . Although an increase in ATP may affect both Ca 2+ and cAMP, the interplay between the messengers is complex, because ATP consumption increases in response to Ca 2+ elevation. The b-cells within islets are coupled by gap junctions (47) 2+ ] pm of several a-cells within an islet was averaged, probably explaining why it has previously escaped detection (42) . In this situation, the phase shift between the average [Ca 2+ ] pm and [ATP] pm oscillations in the a cells seemed identical to that in the b-cells and probably reflects energydependent Ca 2+ extrusion. At 20 mM glucose, glucagon release from isolated islets also is pulsatile and in opposite phase to the insulin pulses (4, 5) , which likely underlies the same phase relationship of the hormone oscillations in the circulation (1, 2) . Ca 2+ is the major trigger of insulin secretion (8) and is generally believed to underlie stimulation of glucagon release (16) (17) (18) (19) (20) (21) . As a consequence, one would expect that the [Ca 2+ ] pm oscillations would be in opposite phase in a-and b-cells. We were therefore perplexed that the highly coherent [Ca 2+ ] pm oscillations in b-cells synchronized with the average [Ca 2+ ] pm oscillations in a-cells. This synchronization was consistent in islets from several preparations studied with different Ca 2+ indicators and probably involves paracrine coordinating factors. In a previous study, it was noticed that although Ca 2+ oscillations are not synchronized among a-cells, oscillations in individual a-cells exposed to 8-12 mM glucose sometimes approximately follow the surrounding coordinated b-cell waves of Ca 2+ (15) . Our data indicate that a-and b-cell Ca 2+ synchrony dominates at glucose concentrations that stimulate insulin secretion. Therefore, glucose may act downstream of Ca 2+ , which is consistent with proposed Ca 2+ -independent inhibition by hyperglycemic concentrations of the sugar (48) .
The present data support a recent suggestion that glucose inhibition of glucagon release is regulated by a-cellintrinsic mechanisms during recovery from hypoglycemia and that paracrine factors become important when the glucose concentration exceeds the thresholds for stimulation of d-and b-cell secretion (49) . The observation that ATP in a-cells is relatively more sensitive to low glucose concentrations in a-than in b-cells is consistent with models that attribute a messenger role to ATP in glucagon secretion. Moreover, SSTR-2 antagonism potently stimulated glucagon release with little effect on [Ca 2+ ] pm , as is expected if somatostatin acts downstream of Ca 2+ (50, 51) . Pulsatile secretion of glucagon in opposite phase to that of insulin and somatostatin (2, 4, 5) as a result may be generated at high glucose, although [Ca 2+ ] pm oscillations were found to be in the same phase in a-and b-cells. However, somatostatin cannot explain all inhibition; present and previous (20) data show that glucose also inhibits glucagon secretion after SSTR-2 blockade and when SSTR signaling is prevented (52, 53) . No evidence was found for an inhibitory role of insulin but it remains to be clarified whether the somatostatin-independent inhibition involves other b-cell factors or reflects only an intrinsic a-cell mechanism.
